• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异位妊娠手术后持续性滋养细胞活性的危险因素。

Risk factors for persistent trophoblastic activity after surgery for ectopic pregnancy.

作者信息

Nathorst-Böös Jörgen, Rafik Hamad Rangeen

机构信息

Karolinska Institute, Department of Woman and Child Health, Division of Obstetrics and Gynecology, c/o Karolinska Hospital, SE-171 76 Stockholm, Sweden.

出版信息

Acta Obstet Gynecol Scand. 2004 May;83(5):471-5. doi: 10.1111/j.0001-6349.2004.00375.x.

DOI:10.1111/j.0001-6349.2004.00375.x
PMID:15059161
Abstract

BACKGROUND

The purpose of this study was to explore the value of preoperative ultrasound and human chorionic gonadotropin (hCG) monitoring to predict the occurrence of residual trophoblastic tissue after laparoscopic conservative surgery for tubal pregnancy.

METHODS

During the period from January 1998 to December 1999 all 206 women undergoing treatment for ectopic pregnancy at the Karolinska hospital were included in the study. A vaginal ultrasound examination was performed and the ectopic size was measured. Serum-hCG levels were recorded preoperatively, and at days 1-2 and 14-21 after surgery.

RESULTS

A diameter of 8 mm or less was observed in 13 of the 14 patients needing secondary treatment. The risk of second surgery if the finding at the preoperative ultrasound was larger than 8 mm was 1/73 resulting in a negative predictive value of 0.01. A considerable overlap in the hCG levels was found on days 1-2 after surgery between women with and without second surgery.

CONCLUSIONS

Using a single cutoff point for hCG seems to be of little value as residual trophoblastic tissue can manifest itself at different times--early or late--during the postoperative period. Women with a small ectopic pregnancy as detected by preoperative vaginal ultrasound are at high risk of developing residual trophoblastic tissue. These patients should be considered by the surgeon and monitored with hCG levels until values decline and become undetectable. Management of patients with slowly but declining values can be conservative. If hCG levels are rising or do not decline, methotrexate (MTX) can be an alternative.

摘要

背景

本研究旨在探讨术前超声检查及人绒毛膜促性腺激素(hCG)监测对预测输卵管妊娠腹腔镜保守手术后滋养细胞残留组织发生情况的价值。

方法

1998年1月至1999年12月期间,卡罗林斯卡医院所有206例接受异位妊娠治疗的女性纳入本研究。进行阴道超声检查并测量异位妊娠包块大小。记录术前、术后第1 - 2天及14 - 21天的血清hCG水平。

结果

14例需要二次治疗的患者中,13例观察到包块直径8mm或更小。如果术前超声检查发现包块大于8mm,二次手术的风险为1/73,阴性预测值为0.01。术后第1 - 2天,有二次手术和无二次手术的女性hCG水平存在相当大的重叠。

结论

由于滋养细胞残留组织可在术后早期或晚期不同时间出现,采用单一hCG临界值似乎价值不大。术前经阴道超声检查发现异位妊娠包块较小的女性发生滋养细胞残留组织的风险较高。外科医生应考虑这些患者,并监测hCG水平,直至其值下降并无法检测到。对于hCG值缓慢下降的患者,管理可较为保守。如果hCG水平上升或未下降,甲氨蝶呤(MTX)可作为一种选择。

相似文献

1
Risk factors for persistent trophoblastic activity after surgery for ectopic pregnancy.异位妊娠手术后持续性滋养细胞活性的危险因素。
Acta Obstet Gynecol Scand. 2004 May;83(5):471-5. doi: 10.1111/j.0001-6349.2004.00375.x.
2
Is serum human chorionic gonadotrophin follow-up necessary after suspected spillage of trophoblast at the time of laparoscopic surgery for ectopic pregnancy?腹腔镜手术治疗异位妊娠时怀疑绒毛外溢后是否需要随访血清人绒毛膜促性腺激素?
Gynecol Obstet Invest. 2011;71(4):225-8. doi: 10.1159/000318221. Epub 2010 Dec 15.
3
Persistent trophoblast after conservative treatment of tubal pregnancy: prediction and detection.输卵管妊娠保守治疗后持续性滋养细胞:预测与检测
Obstet Gynecol. 1991 Jan;77(1):129-33.
4
[Follow-up of beta-hCG after pelviscopic linear salpingotomy for therapy of tubal pregnancy].[输卵管妊娠盆腔镜下线性输卵管切开术后β-人绒毛膜促性腺激素的随访]
Geburtshilfe Frauenheilkd. 1995 Jan;55(1):37-40. doi: 10.1055/s-2007-1022771.
5
Clearance curves of serum human chorionic gonadotrophin for the diagnosis of persistent trophoblast.血清人绒毛膜促性腺激素清除曲线用于诊断持续性滋养层细胞疾病。
Hum Reprod. 1995 Mar;10(3):683-7. doi: 10.1093/oxfordjournals.humrep.a136012.
6
Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.异位妊娠中甲氨蝶呤治疗结局的预测因素:400例病例的对比研究
Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:23-30. doi: 10.1016/j.ejogrb.2016.11.016. Epub 2016 Nov 19.
7
Early and late half-life of human chorionic gonadotropin as a predictor of persistent trophoblast after laparoscopic conservative surgery for tubal pregnancy.
Acta Obstet Gynecol Scand. 2003 Jun;82(6):550-5. doi: 10.1034/j.1600-0412.2003.00154.x.
8
Human chorionic gonadotropin level as a predictor of trophoblastic infiltration into the tubal wall in ectopic pregnancy: a blinded study.人绒毛膜促性腺激素水平作为异位妊娠中滋养层细胞浸润输卵管壁的预测指标:一项盲法研究。
Fertil Steril. 2003 Apr;79(4):981-6. doi: 10.1016/s0015-0282(02)04922-1.
9
Disappearance of human chorionic gonadotropin following removal of ectopic pregnancy.异位妊娠切除术后人绒毛膜促性腺激素的消失
Obstet Gynecol. 1983 Oct;62(4):486-8.
10
Management of patients with persistent beta-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy.腹腔镜手术及局部药物治疗异位妊娠后持续性β-人绒毛膜促性腺激素值患者的管理
Int J Gynaecol Obstet. 1994 Oct;47(1):33-8. doi: 10.1016/0020-7292(94)90458-8.

引用本文的文献

1
Laparoscopic resection of a salpingectomy stump remnant during early pregnancy: the diagnostic challenge posed in diagnosing a heterotopic stump pregnancy.腹腔镜切除早期妊娠输卵管残端:诊断异位残端妊娠所带来的诊断挑战。
BMJ Case Rep. 2024 Mar 12;17(3):e258983. doi: 10.1136/bcr-2023-258983.
2
Predictive values of the ratio of beta-human chorionic gonadotropin for failure of salpingostomy in ectopic pregnancy.β-人绒毛膜促性腺激素比值对异位妊娠输卵管造口术失败的预测价值。
Int J Clin Exp Pathol. 2019 Mar 1;12(3):901-908. eCollection 2019.
3
Clinical characteristics of persistent ectopic pregnancy after salpingostomy and influence on ongoing pregnancy.
输卵管造口术后持续性异位妊娠的临床特征及其对继续妊娠的影响。
J Obstet Gynaecol Res. 2017 Mar;43(3):564-570. doi: 10.1111/jog.13251. Epub 2017 Jan 26.
4
Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies.体外受精-胚胎移植后继发的异位妊娠:发病机制与管理策略
Reprod Biol Endocrinol. 2015 Apr 12;13:30. doi: 10.1186/s12958-015-0025-0.